Cargando...
Is the availability of endoscopic treatment changing the initial management of vesicoureteral reflux?
INTRODUCTION AND OBJECTIVE: The optimal management of vesicoureteral reflux (VUR) continues to be controversial. Since the approval of Dextranomer/Hyaluronic Acid copolymer implants (Dx/HA; Deflux) for endoscopic anti-reflux surgery (EARS) in 2001, the perception that EARS is less morbid than open a...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2009
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2726896/ https://ncbi.nlm.nih.gov/pubmed/19625050 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2009.05.049 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|